APOE and Alzheimer disease: In a recent meta-analysis32, the frequency of APOE e4 carriers was 68.9% vs 52.1% in AD, 52.5% vs 33.3% in MCI, and 35.3% vs 22.5% in control subjects (northern Europe vs Asia)32.